Project Details
Description
A Phase II, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gemcitabine plus Bevacizumab......
| Status | Finished |
|---|---|
| Effective start/end date | 1/8/07 → 6/30/12 |
Funding
- GENENTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.